Galmed Pharmaceuticals (GLMD) Beginning Cash Balance (2014 - 2022)
Galmed Pharmaceuticals (GLMD) posted quarterly Beginning Cash Balance of $7.1 million for Q1 2021, down 55.99% year-over-year from $16.0 million in Q1 2020, and down 55.99% quarter-over-quarter from $16.0 million in Q1 2020.
Galmed Pharmaceuticals (GLMD) Beginning Cash Balance (2014 - 2022) Analysis & Trends
Galmed Pharmaceuticals' Beginning Cash Balance history runs 6 years deep, the most recent figure standing at $7.1 million for Q1 2021.
- In Q1 2021, Beginning Cash Balance fell 55.99% year-over-year to $7.1 million; the TTM figure through Mar 2021 stood at $23.1 million (up 44.01% YoY), while the FY2022 annual figure was $334000.0, changed N/A from the prior year.
- Beginning Cash Balance for Q1 2021 stood at $7.1 million, down from $16.0 million in the prior quarter.
- The five-year high for Beginning Cash Balance was $16.0 million in Q1 2020, with the low at $3.1 million in Q1 2017.
- The 3-year median for Beginning Cash Balance is $7.1 million (2021), against an average of $8.7 million.
- The sharpest annual moves came in 2017 and 2021: Beginning Cash Balance decreased 25.48% in 2017, then sank 55.99% in 2021.
- Galmed Pharmaceuticals' Beginning Cash Balance stood at $3.1 million in 2017, then soared by 418.02% to $16.0 million in 2020, then plunged by 55.99% to $7.1 million in 2021.
- Business Quant data shows GLMD's Beginning Cash Balance at $7.1 million in Q1 2021, $16.0 million in Q1 2020, and $3.1 million in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Galmed Pharmaceuticals | 2.31 Mn | -9.57 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 334,000.00 |
| Dec 31, 2022 | 334,000.00 |
| Mar 31, 2021 | 7.06 Mn |
| Mar 31, 2021 | 7.06 Mn |
| Mar 31, 2020 | 16.04 Mn |
| Mar 31, 2020 | 16.04 Mn |
| Mar 31, 2017 | 3.10 Mn |
| Mar 31, 2017 | 3.10 Mn |
| Mar 31, 2016 | 4.16 Mn |
| Mar 31, 2016 | 4.16 Mn |
| Mar 31, 2015 | 23.74 Mn |
| Mar 31, 2015 | 23.74 Mn |
| Mar 31, 2014 | 137,000.00 |
| Mar 31, 2014 | 137,000.00 |